Tenderwize
Back to tender search

Open-house rebate agreement for Sarilumab

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 05, 2026 · 19 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Sarilumab, ATC L04AC14

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

62 / 100

Complexity

48 / 100

Risk factors

The notice uses an open-procedure form but explicitly says the arrangement is an open-house model and not a normal proc...

The notice references procurement documents and an annex, but only the notice text was provided; the full document set...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2026
  • Non-exclusive open-house rebate agreements for the medicinal product substance Sarilumab, ATC L04AC14.
  • Supply contract for pharmaceutical products.
Show full summary

This is an open-house pharmaceutical supply arrangement for Sarilumab (ATC L04AC14) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the notice states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 2024-11-01 to 2026-10-31, with contract entry possible until 2026-09-05. Submission is allowed electronically with a qualified electronic signature or in paper form, and the notice requires German-language submission or German translation for non-German documents. No contract value is stated.

Risks

The notice uses an open-procedure form but explicitly says the arrangement is an open-house model and not a normal proc...

The notice references procurement documents and an annex, but only the notice text was provided; the full document set...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Sarilumab

Single lot for non-exclusive open-house rebate agreements concerning the pharmaceutical substance Sarilumab (ATC L04AC14). The lot is for supplies and is performance-related to Germany, specifically Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Oct 2024 - Oct 2026

Category

Pharmaceutical products

Deadline

Deadline Sep 05, 2026

Procurement Details

Publication date
16 Sep 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
557248-2024

Documents (2)

Similar tenders